Company: MDCXW
Filing Date: 2025-05-27
Form Type: S-1
Source: 0001062993-25-010394
Chunk: 258

Company: Medicus Pharma Ltd.
Filing Date: 2025-05-27
Form: S-1
Chunk 258
---
 10.12  | Global Guaranty Agreement, by and among the subsidiaries of Medicus Pharma Ltd. set forth in Schedule I thereto, dated May 2, 2025 (incorporated by reference from Exhibit 10.2 to the Registrant's Current Report on Form 8-K, filed with the SEC on May 5, 2025). |
| 21.1   | List of Subsidiaries of Medicus Pharma Ltd. (incorporated by reference from Exhibit 21.1 to the Registrant's Registration Statement on Form F-1, filed with the SEC on May 29, 2024)                                                                                |
| 23.1   | Consent of EisnerAmper LLP                                                                                                                                                                                                                                          |
| 23.2   | Consent of MNP LLP                                                                                                                                                                                                                                                  |
| 23.3   | Consent of Bennett Jones LLP (included in Exhibit 5.1)                                                                                                                                                                                                              |
| 23.4   | Consent of Paul, Weiss, Rifkind, Wharton & Garrison LLP (included in Exhibit 5.2)                                                                                                                                                                                   |
| 24.1   | Powers of Attorney (included in the signature page to this Registration Statement)                                                                                                                                                                                  |
| 107    | Filing fee table                                                                                                                                                                                                                                                    |

____________________________

+Indicates a management contract or compensatory plan.

#Schedules and certain other private or confidential information (as indicated therein) have been omitted pursuant to Item 601(b)(2) of Regulation S-K. The Company hereby undertakes to furnish supplementally copies of any of the omitted schedules upon request by the SEC.

†Certain private or confidential information (as indicated therein) have been redacted pursuant to Item 601(a)(6) of Regulation S-K.

<div align='center'>II-6

SIGNATURES</div>

Pursuant to the requirements of the Securities Act, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized in W. Conshohocken, Pennsylvania this 27 day of May, 2025.

| MEDICUS PHARMA LTD. |                                                       |
| By:                 | /s/ Raza Bokhari                                      |
|                     | Name: Dr. Raza Bokhari                                
 Title: Executive Chairman and Chief Executive Officer |

<div align='center'>II-7

POWERS OF ATTORNEY</div>

KNOW ALL PERSONS BY THESE PRESENTS,